Marie Godar

Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia

Adrian C. Newland, Blanca Sánchez‐González, László Rejtő et al. · American Journal of Hematology · 2019 · 173 citations · Full text

Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial

Catherine M. Broome, Vickie McDonald, Yoshitaka Miyakawa et al. · The Lancet · 2023 · 77 citations · Full text

Thrombopoiesis, Autoimmune Disease, Blood Platelet +11

A bispecific antibody strategy to target multiple type 2 cytokines in asthma

Marie Godar, Kim Deswarte, Karl Vergote et al. · Journal of Allergy and Clinical Immunology · 2018 · 53 citations · Full text

Asthma, Inflammatory Lung Disease, Multiple Type 2 +8

Dual anti-idiotypic purification of a novel, native-format biparatopic anti-MET antibody with improved in vitro and in vivo efficacy

Marie Godar, Virginia Morello, Ava Sadi et al. · Scientific Reports · 2016 · 19 citations · Full text

Efficacy and Safety of Intravenous Efgartigimod in Adults with Primary Immune Thrombocytopenia: Results of a Phase 3, Multicenter, Double-Blinded, Placebo-Controlled, Randomized Clinical Trial (ADVANCE IV)

Catherine M. Broome, Vickie McDonald, Yoshitaka Miyakawa et al. · Blood · 2022 · 13 citations